Chung Hye Yoon, See Cha Ja, Choi Jung Eun, Min Hyun Jung, Cho Han Ik, Lee Dong Soon
Department of Laboratory Medicine, College of Medicine, Seoul National University, Seoul, Korea.
Korean J Lab Med. 2006 Oct;26(5):317-22. doi: 10.3343/kjlm.2006.26.5.317.
Immunoglobulin heavy chain (IgH) gene rearrangement, which is frequently observed in multiple myeloma, can now be detected easily by using a fluorescence in situ hybridization (FISH) method. The aim of this study was to determine the detection rate and compare the utility of the three most commonly used probes: IGH/CCND1 dual color, dual fusion probe; IGH/BCL2 dual color, dual fusion probe; and IGH dual color break apart rearrangement probe; all from Vysis Products (Downers Grove, IL, USA).
From October 1994 to July 2003, 99 patients were diagnosed as multiple myeloma at Seoul National University Hospital, Asan Medical Center and Gachon University Gil hospital. We applied the three different probes of IgH FISH on bone marrow specimens from the 99 Korean patients with multiple myeloma to detect IgH gene rearrangement.
Forty-one (41.4%) of the 99 patients had IgH gene rearrangement. Of those 41 patients, 23 (56.1%) showed positive to all three probes, but the remaining 18 (43.9%) showed a discrepancy between the three probes: 13 (72.2%) of the 18 patients were only positive to the IGH dual color break apart rearrangement probe and the detection rate was 39.6% on the average.
These results demonstrate that IGH dual color break apart rearrangement probe is superior to the other two probes in qualitative and quantitative ways. Thus, we recommend IGH dual color break apart rearrangement probe for the diagnosis and monitoring of multiple myeloma.
免疫球蛋白重链(IgH)基因重排常见于多发性骨髓瘤,目前可通过荧光原位杂交(FISH)方法轻松检测到。本研究的目的是确定检测率,并比较三种最常用探针的效用:IGH/CCND1双色双融合探针;IGH/BCL2双色双融合探针;以及IGH双色分离重排探针;均来自美国伊利诺伊州唐纳斯格罗夫的Vysis产品公司。
1994年10月至2003年7月,99例患者在首尔国立大学医院、峨山医疗中心和加川大学吉尔医院被诊断为多发性骨髓瘤。我们对99例韩国多发性骨髓瘤患者的骨髓标本应用三种不同的IgH FISH探针来检测IgH基因重排。
99例患者中有41例(41.4%)发生IgH基因重排。在这41例患者中,23例(56.1%)对所有三种探针均呈阳性,但其余18例(43.9%)在三种探针之间存在差异:18例患者中有13例(72.2%)仅对IGH双色分离重排探针呈阳性,平均检测率为39.6%。
这些结果表明,IGH双色分离重排探针在定性和定量方面均优于其他两种探针。因此,我们推荐使用IGH双色分离重排探针来诊断和监测多发性骨髓瘤。